CSL confirms there was a positive COVID-19 case at its Broadmeadows manufacturing facility last week. All employees and contractors who were present at the same time as the confirmed case have been tracked and traced, and close contacts isolated. We are pleased that there have been no further positive cases identified. A deep clean was undertaken at the facility and it continues to operate as usual with no interruption to the production of CSL's lifesaving therapies and vaccines, including production of AstraZeneca vaccine at our Parkville site.
As a science-based company which includes the world's second largest provider of influenza vaccines, we have a comprehensive understanding and appreciation for the public health value that vaccines provide. We therefore strongly encourage all of our people, their families and every Australian to get vaccinated against COVID-19.
